Inventor · disambiguated record
Hidekazu Tokuhara
Also filed as: TOKUHARA HIDEKAZU
23 granted patents·5 pending applications·71 citations·filing 2008–2023
94Inventor score
Files withTAKEDA PHARMACEUTICALS CO18KUROITA TAKANOBU5TAKEDA PHARMACEUTICAL3ASKA PHARM CO LTD1MATSUNAGA NOBUYUKI1
Top patents by PatentIndex Score
28 records- 0193US11230545B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jan 25, 2022·2 cites·4 claims
- 0293US10610520B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Apr 7, 2020·9 cites·12 claims
- 0393US10323026B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 18, 2019·20 cites·10 claims
- 0491US9365520B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2015·Granted Jun 14, 2016·9 cites·2 claims
- 0587US9573903B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Feb 21, 2017·5 cites·2 claims
- 0686US10106556B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Oct 23, 2018·8 cites·20 claims
- 0782US10472376B2Amide compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Nov 12, 2019·5 cites·13 claims
- 0880US11274101B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Mar 15, 2022·1 cites·12 claims
- 0979US8466282B2Heterocyclic compound and use thereofKUROITA TAKANOBU·Filed 2009·Granted Jun 18, 2013·3 cites·1 claims
- 1078US11407748B2Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor functionTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 9, 2022·1 cites·12 claims
- 1176US11053262B2Heterocyclic amide compounds having RORyT inhibitory actionTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jul 6, 2021·1 cites·22 claims
- 1276US9624170B24-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Apr 18, 2017·3 cites·16 claims
- 1374US12435063B2Nitrogen containing heterocycles as CDK12 inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Oct 7, 2025·0 cites·15 claims
- 1474US9630924B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Apr 25, 2017·1 cites·2 claims
- 1573US11851449B2Heterocyclic amide compounds having an RORvt inhibitory actionTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Dec 26, 2023·0 cites·11 claims
- 1673US8664380B2Heterocyclic compound and use thereofKUROITA TAKANOBU·Filed 2009·Granted Mar 4, 2014·1 cites·1 claims
- 1770US9045436B2Heterocyclic compound and use thereofKUROITA TAKANOBU·Filed 2012·Granted Jun 2, 2015·1 cites·12 claims
- 1863US11584737B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Feb 21, 2023·0 cites·15 claims
- 1963US9023858B2Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitorsMATSUNAGA NOBUYUKI·Filed 2011·Granted May 5, 2015·1 cites·12 claims
- 2063US2025340557A1Pyrimidine derivativeASKA PHARM CO LTD·Filed 2023·Application pending·0 cites
- 2160US9650343B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted May 16, 2017·0 cites·2 claims
- 2256US10093629B2Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Oct 9, 2018·0 cites·9 claims
- 2354US10053468B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Aug 21, 2018·0 cites·18 claims
- 2454US9221836B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICAL·Filed 2015·Granted Dec 29, 2015·0 cites·8 claims
- 2553US2016046601A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICAL·Filed 2015·Application pending·0 cites
- 2650US2018319812A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Application pending·0 cites
- 2750US2009227560A1Substituted imidazole compound and use thereofKUROITA TAKANOBU·Filed 2008·Application pending·0 cites
- 2846US2009156612A1Substituted imidazole compound and use thereofKUROITA TAKANOBU·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →